Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 2

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Radiation Enteritis 1Pancreatic Adenocarcinoma Metastatic 1

Interventions

Cisplatin 1514Carboplatin 1416Cyclophosphamide 1359Gemcitabine 1235Bevacizumab 1223Paclitaxel 1210Radiotherapy 1173Docetaxel 1079pembrolizumab 1026Oxaliplatin 934Capecitabine 898Fluorouracil 832Rituximab 729Doxorubicin 683Nivolumab 679Dexamethasone 665Etoposide 660Irinotecan 622Leucovorin 574Pemetrexed 508Drug Therapy 491Cetuximab 481Trastuzumab 467Cytarabine 466Magnetic Resonance Spectroscopy 457Filgrastim 446Prednisone 432Lenalidomide 409Specimen Handling 407Temozolomide 400

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × sapropterin × Clear all
NCT06396637 2024-05-02

PD-1 Antibody and Sapropterin Dihydrochloride in Patients With PDAC

Sun Yat-sen University

Phase 2 Unknown
20 enrolled
Gastrointestinal

Pancreatic Adenocarcinoma Metastatic

NCT05138887 2022-03-02

A Study for Assessing the Efficacy and Safety of BH4 in Radiation Enteritis

West China Second University Hospital

Phase 2 Unknown
366 enrolled

Radiation Enteritis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡